The aim of this study is to investigate the effects of oxaliplatin-induced peripheral neuropathy on hand function, grip strength, and quality of life in colorectal cancer patients. Assessing the motor symptoms of CIPN and sharing the results in clinical settings will help guide evidence-based practices and interventions.
Age range
20 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Hand Grip Strength Assessment
Timeframe: baseline only
Finger Grip Strengths (Tip, Key, and Palmar Grip)
Timeframe: baseline only
Hand Function Assessment (Duruöz Hand Index)
Timeframe: baseline
Hand Function Assessment (Michigan Hand Outcomes Questionnaire)
Timeframe: baseline
Fine Motor Skill Assessment (Minnesota Manual Dexterity Test)
Timeframe: baseline
Nine-Hole Peg Test (NHPT)
Timeframe: Baseline